OA10157A - Antimalarial drug - Google Patents
Antimalarial drug Download PDFInfo
- Publication number
- OA10157A OA10157A OA60662A OA60662A OA10157A OA 10157 A OA10157 A OA 10157A OA 60662 A OA60662 A OA 60662A OA 60662 A OA60662 A OA 60662A OA 10157 A OA10157 A OA 10157A
- Authority
- OA
- OAPI
- Prior art keywords
- antimalarial drug
- quinine
- sulfated
- crds
- antimalarial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23329693 | 1993-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA10157A true OA10157A (en) | 1996-12-18 |
Family
ID=16952886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60662A OA10157A (en) | 1993-09-20 | 1995-05-19 | Antimalarial drug |
Country Status (9)
Country | Link |
---|---|
US (1) | US5780452A (ja) |
EP (1) | EP0676206B1 (ja) |
JP (1) | JP3718849B2 (ja) |
CA (1) | CA2148607A1 (ja) |
CZ (1) | CZ128095A3 (ja) |
DE (1) | DE69422496T2 (ja) |
ES (1) | ES2142407T3 (ja) |
OA (1) | OA10157A (ja) |
WO (1) | WO1995008334A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2414320C (en) | 2000-06-30 | 2008-04-01 | Polydex Pharmaceuticals Limited | Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
EP1552823A3 (en) * | 2000-06-30 | 2005-09-21 | Polydex Pharmaceuticals Limited | Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
EP1329452A1 (en) * | 2000-10-20 | 2003-07-23 | Ajinomoto Co., Inc. | Medicinal compositions, dose and method for treating malaria |
FR2998176B1 (fr) * | 2012-11-16 | 2015-01-16 | Univ Blaise Pascal Clermont Ii | Composition de polysaccharide sulfate |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1129148B (de) * | 1960-10-19 | 1962-05-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe |
GB1227830A (ja) * | 1968-07-18 | 1971-04-07 | ||
US4197643A (en) * | 1978-03-14 | 1980-04-15 | University Of Connecticut | Orthodontic appliance of titanium alloy |
DE3601136A1 (de) * | 1986-01-16 | 1987-07-23 | Max Planck Gesellschaft | Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren |
US4807177A (en) * | 1986-06-06 | 1989-02-21 | Ward Richard J | Multiple format hand held label printer |
US5512672A (en) * | 1988-07-07 | 1996-04-30 | Ajinomoto Co., Inc. | Curdlan sulfate |
JPH0725802B2 (ja) * | 1988-11-28 | 1995-03-22 | 味の素株式会社 | カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法 |
JPH03218317A (ja) * | 1988-12-06 | 1991-09-25 | Japan Found Cancer Res | 抗レトロウイルス剤 |
JP2772813B2 (ja) * | 1989-03-03 | 1998-07-09 | サッポロビール株式会社 | 抗ウイルス作用と免疫賦活作用を有する組成物 |
SE9003181D0 (sv) * | 1990-10-04 | 1990-10-04 | Kabivitrum Ab | Use of heparin fraction |
-
1994
- 1994-09-20 ES ES94927070T patent/ES2142407T3/es not_active Expired - Lifetime
- 1994-09-20 DE DE69422496T patent/DE69422496T2/de not_active Expired - Lifetime
- 1994-09-20 JP JP50968495A patent/JP3718849B2/ja not_active Expired - Fee Related
- 1994-09-20 EP EP94927070A patent/EP0676206B1/en not_active Expired - Lifetime
- 1994-09-20 US US08/424,493 patent/US5780452A/en not_active Expired - Fee Related
- 1994-09-20 CZ CZ951280A patent/CZ128095A3/cs unknown
- 1994-09-20 CA CA002148607A patent/CA2148607A1/en not_active Abandoned
- 1994-09-20 WO PCT/JP1994/001544 patent/WO1995008334A1/ja active IP Right Grant
-
1995
- 1995-05-19 OA OA60662A patent/OA10157A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ128095A3 (en) | 1995-10-18 |
EP0676206A4 (ja) | 1995-10-25 |
CA2148607A1 (en) | 1995-03-30 |
EP0676206B1 (en) | 2000-01-05 |
EP0676206A1 (en) | 1995-10-11 |
DE69422496T2 (de) | 2002-07-11 |
WO1995008334A1 (fr) | 1995-03-30 |
JP3718849B2 (ja) | 2005-11-24 |
ES2142407T3 (es) | 2000-04-16 |
DE69422496D1 (de) | 2000-02-10 |
US5780452A (en) | 1998-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5292772A (en) | Method for the prevention and control of epileptic seizure associated with Lennox-Gastaut syndrome | |
Rieckmann et al. | Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum | |
US4435449A (en) | Treatment of minimal brain dysfunction (MBD) | |
IL124977A0 (en) | Oral administration of effective amounts of forms of hyaluronic acid | |
US4438138A (en) | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone | |
RU95121731A (ru) | Применение рилузола для лечения нейро-спида и способ получения лекарственного средства | |
US4425363A (en) | Treatment of tardive dyskinesia in mammals | |
Wilairatana et al. | Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. | |
OA10157A (en) | Antimalarial drug | |
US5011841A (en) | Treatment of depression | |
Rieckmann et al. | Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand | |
US5817642A (en) | Clearing of atherosclerosis | |
JPH0352815A (ja) | 血管内血液凝固症候群の治療剤 | |
NZ217431A (en) | Synergistically antimalarial combination preparations comprising an iron(iii) chelating agent and a schizontocide | |
US8304440B2 (en) | Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria | |
JP2003519088A (ja) | Hiv感染患者の治療および予防のためのgssgレダクターゼの使用 | |
US4680311A (en) | Method for the treatment of systemic mycosis | |
US5486535A (en) | Method for treating toxoplasmosis | |
US5886000A (en) | Anti-HIV agent | |
WO1995029683A1 (en) | Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis | |
CA2356453A1 (en) | Anti-hiv infection agents and method for treating hiv infection | |
Walker et al. | Modified Dosing Schedule Efficacy of Fosmidomycin and Clindamycin Against Murine Malaria Plasmodium berghei | |
IE55181B1 (en) | Treatment of minimal brain dysfunction(mbd) | |
CA1307740C (en) | Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus | |
US3636208A (en) | Method for treating malaria |